Head of Commercial Launch Excellence

Role: Head of Commercial Launch Excellence responsible for orchestrating the transition of Abivax's lead IBD therapy from development to successful market launch. Key objectives include developing and executing an integrated launch roadmap, establishing governance and operational infrastructure, and aligning cross-functional teams for launch readiness. Responsibilities encompass strategic planning, enterprise-wide coordination, stakeholder communication, governance support, performance monitoring, and post-launch optimization. The role also involves leading external support functions, preparing executive and board materials, and driving continuous improvement for future expansion. Requirements include a Bachelor’s degree, 10+ years in biotech, pharma, or healthcare consulting, with proven experience in launch planning, strategic operations, and cross-functional leadership within matrixed environments. Preferred qualifications are advanced degrees (MBA, PharmD, PhD), and experience supporting launches in specialty pharma, immunology, or gastroenterology, especially in IBD or inflammation assets. The candidate must demonstrate strong strategic judgment, executive presence, influence skills, and operational rigor, capable of navigating ambiguity and leading organizational growth. This high-impact role requires collaboration across clinical, medical, regulatory, commercial, and corporate functions in a fast-paced biotech setting, supporting the company’s shift toward commercialization.